• Interview with Olink’s CEO in Business Trends

    Business Trends magazine recently interviewed Olink Proteomics CEO, Jon Heimer and have published an article in which he outlines the company’s commitment to support the development of precision medicine by providing enabling solutions for protein biomarker discovery, development and implementation. He also discusses Olink’s recent acquisition by Summa Equity, and how the commitment of our new owners will enable the company to more rapidly expand its global reach. Click the image/link below to read or download the complete interview.

    Read the article now.